113 related articles for article (PubMed ID: 12489807)
1. The development of insulitis and the kallikrein-kinin system.
Zucollo A; Dziubecki D; Villareal I; Rodriguez R; Catanzaro O
Int Immunopharmacol; 2002 Dec; 2(13-14):1941-7. PubMed ID: 12489807
[TBL] [Abstract][Full Text] [Related]
2. Effects of aprotinin on the kallikrein-kinin system in type I diabetes (insulitis).
Zuccollo A; Frontera M; Cueva F; Navarro M; Catanzaro OL
Immunopharmacology; 1997 Oct; 37(2-3):251-6. PubMed ID: 9403344
[TBL] [Abstract][Full Text] [Related]
3. Bradykinin excretion is increased in severely hyperglycemic streptozotocin-diabetic rats.
Tschöpe C; Gavriluk V; Reinecke A; Seidl U; Riester U; Hilgenfeldt U; Ritz E; Unger T
Immunopharmacology; 1996 Jun; 33(1-3):344-8. PubMed ID: 8856182
[TBL] [Abstract][Full Text] [Related]
4. Kinin, a mediator of diabetes-induced glomerular hyperfiltration.
Jaffa AA; Rust PF; Mayfield RK
Diabetes; 1995 Feb; 44(2):156-60. PubMed ID: 7859934
[TBL] [Abstract][Full Text] [Related]
5. Effects of B1 and B2 kinin receptor antagonists in diabetic mice.
Zuccollo A; Navarro M; Catanzaro O
Can J Physiol Pharmacol; 1996 May; 74(5):586-9. PubMed ID: 8884024
[TBL] [Abstract][Full Text] [Related]
6. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.
Vora JP; Oyama TT; Thompson MM; Anderson S
Diabetes; 1997 Jan; 46(1):107-12. PubMed ID: 8971089
[TBL] [Abstract][Full Text] [Related]
7. Functional, biochemical, and molecular investigations of renal kallikrein-kinin system in diabetic rats.
Tschöpe C; Reinecke A; Seidl U; Yu M; Gavriluk V; Riester U; Gohlke P; Graf K; Bader M; Hilgenfeldt U; Pesquero JB; Ritz E; Unger T
Am J Physiol; 1999 Dec; 277(6):H2333-40. PubMed ID: 10600853
[TBL] [Abstract][Full Text] [Related]
8. Urinary active kallikrein excretion and diabetic renal impairments in streptozotocin-treated rats.
Yasujima M; Yoshida K; Kanazawa M; Kohzuki M; Omata K; Watanabe H; Hiwatari M; Sato T; Abe K
Tohoku J Exp Med; 1993 Oct; 171(2):135-44. PubMed ID: 8128482
[TBL] [Abstract][Full Text] [Related]
9. Decreased urinary kallikrein with hyperglycemia in patients with short-term insulin-dependent diabetes mellitus.
Pelikánová T; Pinsker P; Smrcková I; Stribrná L; Dryáková M
J Diabetes Complications; 1998; 12(5):264-72. PubMed ID: 9747643
[TBL] [Abstract][Full Text] [Related]
10. Renal kallikrein and hemodynamic abnormalities of diabetic kidney.
Harvey JN; Jaffa AA; Margolius HS; Mayfield RK
Diabetes; 1990 Mar; 39(3):299-304. PubMed ID: 1689683
[TBL] [Abstract][Full Text] [Related]
11. Renal function in the diabetic pregnant rats.
Marina-Prendes MG; Zuccollo A; Catanzaro OL
Acta Physiol Pharmacol Ther Latinoam; 1999; 49(2):65-70. PubMed ID: 10797842
[TBL] [Abstract][Full Text] [Related]
12. Urinary kallikrein excretion in type 1 (insulin-dependent) diabetes mellitus.
Manto A; Cotroneo P; Porcelli G; D'Errico G; Marra G; Magnani P; Tilli P; Greco AV; Ghirlanda G
Diabetologia; 1993 May; 36(5):423-7. PubMed ID: 8314446
[TBL] [Abstract][Full Text] [Related]
13. Urinary and renal tissue kallikrein in the streptozocin-diabetic rat.
Mayfield RK; Margolius HS; Bailey GS; Miller DH; Sens DA; Squires J; Namm DH
Diabetes; 1985 Jan; 34(1):22-8. PubMed ID: 3843806
[TBL] [Abstract][Full Text] [Related]
14. The involvement of kallikrein-kinin system in diabetes type I (insulitis).
Zuccollo A; Navarro M; Frontera M; Cueva F; Carattino M; Catanzaro OL
Immunopharmacology; 1999 Dec; 45(1-3):69-74. PubMed ID: 10614992
[TBL] [Abstract][Full Text] [Related]
15. Renal alteration and development of hypertension in diabetic rats.
Pellufo V; Costa MA; Prendes MG; Catanzaro OL
Agents Actions Suppl; 1992; 38 ( Pt 2)():50-7. PubMed ID: 1462845
[TBL] [Abstract][Full Text] [Related]
16. Urinary kallikrein excretion is low in malignant essential hypertension.
Hilme E; Herlitz H; Gyzander E; Hansson L
J Hypertens; 1992 Aug; 10(8):869-74. PubMed ID: 1325521
[TBL] [Abstract][Full Text] [Related]
17. Roles of renal dopamine and kallikrein-kinin systems in antihypertensive mechanisms of exercise in rats.
Maeda H; Sasaguri M; Sakai T; Kinoshita A; Koga M; Noda K; Tsuji E; Ideishi M; Arakawa K
Hypertens Res; 2000 Sep; 23(5):511-9. PubMed ID: 11016807
[TBL] [Abstract][Full Text] [Related]
18. Streptozotocin-induced hyperglycemia is decreased by nitric oxide inhibition.
Catanzaro OL; Marina-Prendes MG; Hope SI; Zuccollo A; Dominguez A
Braz J Med Biol Res; 1994 Aug; 27(8):2043-7. PubMed ID: 7749393
[TBL] [Abstract][Full Text] [Related]
19. Chronic indomethacin administration and its relation with the renal kallikrein kinin system during rat pregnancy.
Oddo EM; Negri AL; Santos JC; Martín RS; Arrizurieta EE
Medicina (B Aires); 1993; 53(4):326-32. PubMed ID: 8201915
[TBL] [Abstract][Full Text] [Related]
20. The relationship between urinary kallikrein and glomerular filtration rate (GFR) in type-1 diabetes: studies with lithium.
Platts JK; Meadows P; Harvey JN
Immunopharmacology; 1996 Jun; 33(1-3):351-3. PubMed ID: 8856184
[No Abstract] [Full Text] [Related]
[Next] [New Search]
